This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roger Brown, H. Articles by Morgan, K. T. Search for Related Content PubMed PubMed Citation Articles by Roger Brown, H. Articles by Morgan, K. T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood and Blood Disorders Cardiomyopathy Hazardous Substances DB DOXORUBICIN Social Bookmarking                         What's this?

Correlation of Simultaneous Differential Gene Expression in the Blood and Heart with Known Mechanisms of Adriamycin-Induced Cardiomyopathy in the Rat

Drug Safety, Toxicogenomics, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709, hrb25873{at}gsk.com

Hong Ni

Drug Safety, Toxicogenomics, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

Gina Benavides

Drug Safety, Toxicogenomics, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

Lawrence Yoon

Drug Safety, Toxicogenomics, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

Karim Hyder

Clontech Laboratories, Inc, Palo Alto, California 94303

Jaisri Giridhar

Medicine Safety Evaluation, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

Guy Gardner

Medicine Safety Evaluation, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

Ronald D. Tyler

Drug Safety, Toxicogenomics, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

Kevin T. Morgan

Drug Safety, Toxicogenomics, GlaxoSmithKline, Inc, Research Triangle Park, North Carolina 27709

As the genomes of mammalian species become sequenced and gene functions are ascribed, the use of differential gene expression (DGE) to evaluate organ function will become common in the experimental evaluation of new drug therapies. The ability to translate this technology into useful information for human exposures depends on tissue sampling that is impractical or generally not possible in man. The possibility that the DGE of nucleated cells, reticulocytes, or platelets in blood may present the necessary link with target organ toxicity provides an opportunity to correlate preclinical with clinical outcomes. Adriamycin is highly effective alone and more frequently in combination with other chemotherapeutic agents in the treatment of a variety of susceptible malignancies. Adriamycin-induced cardiomyopathy was examined as an endpoint to measure the utility of DGE on whole blood as a predictor of cardiac toxicity. Statistically significant gene changes were observed between relevant blood and cardiac gene profiles that corroborated the accepted mechanisms of toxicity (oxidative stress, effects on carnitine transport, DNA intercalation). There were, however, clear indications that other target organs (bone marrow and intestinal tract) were affected. The divergent expression of some genes between the blood and the heart on day 7 may also indicate the timing and mechanism of development of the cardiomyopathy and confirm current therapeutic approaches for its prevention. The data demonstrate that whole blood gene expression particularly in relation to oxidative stress, in conjunction with standard hematology and clinical chemistry, may be useful in monitoring and predicting cardiac damage secondary to adriamycin administration. Appendices A & B, referenced in this paper, are not printed in this issue of Toxicologic Pathology. They are available as downloadable text files at http://taylorandfrancis.metapress.com/openurl.asp?genre = journal&issn = 0192-6233. To access them, click on the issue link for 30(4), then select this article. A download option appears at the bottom of this abstract. In order to access the full article online, you must either have an individual subscription or a member subscription accessed through www.toxpath.org.

Key Words: Blood • heart • gene expression • doxorubicin.

References

• Khetawat G., Faraday N., Nealen ML, Vijayan KV, Bolton E., Noga SJ, Bray PF ( 2000). Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): Testosterone regulates AR expression. Blood 95: 2289—2296.[Abstract/Free Full Text]
• Brugnara C. (2000). Reticulocyte cellular indices: A new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 37: 93—130.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Doroshow JH, Locker GY, Myers CE (1980). Enzymatic defenses of the mouse heart against reactive oxygen metabolites. J Clin Invest 65: 128— 135.
• Crosby LM, Hyder KS, DeAngelo AB, Kepler TB, Gaskill B., Benavides GR, Yoon L., Morgan KT (2000). Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells. Toxicol Appl Pharmacol 169: 205—221.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Billingham ME, Mason JW, Bristow MR, Daniels JR (1978). Anthracycline cardiomyopathy monitered by morphologic changes. Cancer Treat Rep 62: 865—872.[Web of Science][Medline] [Order article via Infotrieve]
• Rowan RA, Masek MA, Billingham ME (1988). Ultrastructural morphometric analysis of endomyocardial biopsies. Am J Cardiovasc Pathol 2: 137—144.[Medline] [Order article via Infotrieve]
• Bristow MR (1978). Early anthracycline cardiotoxicity. Am J Med 65: 823— 832.
• Yamashita J., Ogawa M., Shirakusa T. (1995). Plasma endothelin-1 as a marker for doxorubicin cardiotoxicity. Int J Cancer 62: 542—547.[Web of Science][Medline] [Order article via Infotrieve]
• Kang YJ, Zhou ZX, Wang GW, Buridi A., Klein JB (2000). Suppression by Metallothionein of Doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 miton-activated protein kinases. J Biol Chem 275: 13690— 13698.[Abstract/Free Full Text]
• Yen HC, Oberley TD, Vichitbandha S., Ho YS, St Clair DK (1996). The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 98: 1253— 1260.
• Sayed-Ahmed MM, Shaaraway S., Shouman SA, Osman AM (1999). Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine. Pharmacol Res 39: 289—295.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Abdel-aleem S., el-Merzabani MM, Sayed-Ahmed M., Taylor DA, Lowe JE (1997). Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J Mol Cell Cardiol 29: 789—797.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Andrieu-Abadie N., Jaffrezou JP, Hatem S., Laurent G., Levade T., Mercaider JJ (1999). L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation. FASEB J 13: 1501— 1510.
• Kapelko VI, Williams CP, Gutstein DE, Morgan JP (1996). Abnormal myocardial calcium handling in the early stage of adriamycin cardiomyopathy. Arch Physiol Biochem 104: 185—191.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Boucek Rjj, Miracle A., Anderson M., Engelman R., Atkinson J., Dodd DA ( 1999). Persistant effects of doxorubicin on cardiac gene expression. J Mol Cell Cardiol 31: 1435—1446.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sazuka Y., Tanizawa H., Takino Y. (1989). Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity. Jpn J Cancer Res 80: 1000—1005.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Arnaiz SL, Llesuy S. (1993). Oxidative stress in mouse heart by antitumoral drugs: A comparative study of doxorubicin and mitoxantrone. Toxicology 77: 31—38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Crescimanno M., Flandina C., Rausa L., Sanguedolce R., D'Alessandro N. (1988). Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone. Chemioterapia 7: 53—59.[Web of Science][Medline] [Order article via Infotrieve]
• D'Alessandro N., Rausa L., Crescimanno M. (1988). In vivo effects of doxorubicin and isoproterenol on reduced glutathione and H2O2 production in mouse heart. Res Comm Chem Pathol Pharmacol 62: 19—30.[CrossRef]
• Yin X., Wu H., Chen Y., Kang YJ ( 1998). Induction of antioxidants by adriamycin in mouse heart. Biochem Pharmacol 56: 87—93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Frankel D., Mehindate K., Schipper HM (2000). Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J Cell Physiol 185: 80—86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nakamura T., Ueda Y., Juan Y., Katsuda S., Takahashi H., Koh E. (2000). Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. Circulation 102: 572—578.[Abstract/Free Full Text]
• Toyoda Y., Okada M., Kashem MA (1998). A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. J Thor Cardiovasc Surg 115: 1367—1373.[Abstract/Free Full Text]
• Ruwhof C., van der Laarse A. (2000). Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways. Cardiovasc Res 47: 23—37.[Abstract/Free Full Text]
• Pinkus R., Weiner LM, Daniel V. (1995). Role of quinone-mediated generation of hydroxyl radical in the induction of glutathione S-transferase gene expression. Biochemistry 34: 81—88.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Jeyaseelan R., Poizat C., Wu HY, Kedes L. (1997). Molecular mechanisms of doxorubicin-induced cardiomyopathy. J Biol Chem 272: 5828—5832.[Abstract/Free Full Text]
• Gewirtz DA (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and dauorubicin. Biochem Pharmacol 57: 727—741.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M. (2000). Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023—16029.[Abstract/Free Full Text]
• Dhakshinamoorthy S., Long DJ2nd, Jaiswal AK (2000). Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36: 201—216.[Web of Science][Medline] [Order article via Infotrieve]
• Parrilli G., Iaffaioli RV, Martorano M., Cuomo R., Tafuto S., Zampino MG, Budillon G., Bianco AR (1989). Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res 49: 3689— 3691.
• Sun Z., Wang X., Wallen R., Deng X., Du X., Hallberg E., Andersson R. (1998). The influence of apoptosis on intestinal barrier integrity in rats. Scand J Gastroenterol 33: 415—422.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Okubo S., Yasunaga K. (1983). Clinical and experimental studies on DIC found in carcinoma; correlation between anti-cancer drug administration and endotoxemia. Jpn J Cancer Clin 29: 803—806.
• Janssen-Heininger YMW, Poynter ME, Baeuerle PA (2000). Recent advances towards understanding redox mechanisms in the activation of nuclear factor β. Free Radic Biol Med 28: 1317—1327.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cowan DB, Poutias DN, Del Nido PJ, McGowan FXJ (2000). CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin. Am J Physiol Heart Circ Physiol 279: H619—629.[Abstract/Free Full Text]
• Chen CC, Wang JK ( 1999). p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 55: 481—488.[Abstract/Free Full Text]
• Chen G., McCuskey RS, Reichlin S. (2000). Blood interleukin-6 and tumor necrosis factor-alpha elevation after intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors: Peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism. Neuroimmunomodulation 8: 59—69.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Matsumoto T., Tateda K., Miyazaki S., Furuya N., Ohno A., Ishii Y., Hirakata Y., Yamaguchi K. (1999). Fosfomycin alters lipopolysaccharide-induced inflammatory cytokine production in mice. Antimicrob Agents Chemother 43: 697—698.[Abstract/Free Full Text]
• Mustapha S., Kirshner A., De Moissac D., Kirshenbaum LA (2000). A direct requirement of nuclear factor-β for suppression of apoptosis in ventricular myocytes. Am J Physiol Heart Circ Physiol 279: H939—H945.[Abstract/Free Full Text]
• Pogrebniak HW, Matthews W., Pass HI (1991). Chemotherapy amplifies production of tumor necrosis factor. Surgery 110: 231—237.[Web of Science][Medline] [Order article via Infotrieve]
• Eriksson C., Nobel S., Winblad B., Schultzberg M. (2000). Expression ofinterleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides. Cytokine 12: 423—431.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Stefanelli C., Pignatti C., Tantini B., Stanic I., Bonavita F., Muscari C., Guarnieri C., Clo C., Caldarera CM (1999). Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim Biophys Acta 1450: 406—413.[Medline] [Order article via Infotrieve]
• Kibbe MR, Li J., Nie S., Watkins SC, Lizonova A., Kovesdi I., Simmons RL, Billiar TR, Tzeng E. (2000). Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31: 1214—1228.[Web of Science][Medline] [Order article via Infotrieve]
• Weinstein DM, Mihm MJ, Bauer JA (2000). Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 294: 396—401.[Abstract/Free Full Text]
• Tabrizi SJ, Schapira AH (1999). Secondary abnormalities of mitochondrial DNA associated with neurodegeneration. Biochem Soc Symp 66: 99—110.[Medline] [Order article via Infotrieve]
• Yen HC, Oberley TD, Gairola CG, Szweda LI, St Clair DK (1999). Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys 362: 59—66.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nagase I., Yoshida S., Canas X., Irie Y., Kimura K., Yoshida T., Saito M. (1999). Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett 461: 319—322.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Valdes Olmos RA, tBHww, ten Hoeve RF, van Tinteren H., Bruning PF, van Vlies B., Hoefnagel CA (1995). Assessment of anthracycline-related myocardial adrenergic derangement by metaiodobenzylguanidine scintigraphy. Eur J Cancer 31A: 26—31.[Medline] [Order article via Infotrieve]
• Tretyakova NY, Wishnok JS, Tannenbaum SR (2000). Peroxynitrite-induced secondary oxidative lesions at guanine nucleobases: Chemical stability and recognition by the Fpg DNA repair enzyme. Chem. Res. Toxicol. 13: 658—664.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tretyakova NY, Burney S., Pamir B., Wishnok JS, Dedon PC, Wogan GN, Tannenbaum SR (2000). Peroxynitrite-induced DNA damage in the supF gene: Correlation with the mutational spectrum. Mutat Res 447: 287—303.[Web of Science][Medline] [Order article via Infotrieve]
• Codegoni AM, Broggini M., Pitelli MR, Pantarotto M., Torri V., Mangioni C., D'Incalci M. (1997). Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer. Gynecol Oncol 65: 130—137.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Satyamoorthy K., Perchellet JP (1989). Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 49: 5364—5370.[Abstract/Free Full Text]
• Casti A., Guarnieri C., Dall'asta R., Clo C. (1977). Effect of spermine on acetylation of histones in the rabbit heart. J Mol Cell Cardiol 9: 63—71.[Web of Science][Medline] [Order article via Infotrieve]
• Cohen SC (1998). A Guide To The Polyamines. Oxford University Press, New York.
• Hobbs CA, Gilmour SK (2000). High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyper-acetylation. J Cell Biochem 77: 345—360.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Flamigni F., Facchini A., Capanni C., Stefanelli C., Tantini B., Caldarera CM (1999). p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J 341: 363—369.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Friberg P., Isgaard J., Wahlander A., Wickman A., Adams MA (1998). Inhibited expression of insulin-like growth factor I mRNA and attenuated cardiac hypertrophy in volume overloaded hearts treated with difluoromethylornithine. Growth Horm IGF Res 8: 159—165.[Web of Science][Medline] [Order article via Infotrieve]
• Schluter KD, Frischkopf K., Flesch M., Rosenkranz S., Taimor G., Piper HM (2000). Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy. Cardiovasc Res 45: 410—417.[Abstract/Free Full Text]
• Wang GW, Kang YJ ( 1998). Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. J Pharmacol Exp Ther 288: 938—944.[Web of Science]
• Stefanelli C., Stanic I., Zini M., Bonavita F., Flamigni F., Zambonin L., Landi L., Pignatti C., Guarnieri C., Caldarera CM (2000). Polyamines directly induce release of cytochrome c from heart mitochondria. Biochem J 347: 875—880.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kurabayashi M., Dutta S., Jeyaseelan R., Kedes L. (1995). Doxorubicin-induced Id2A gene transcription is targeted at an activating transcription factor/cyclic AMP response element motif through novel mechanisms involving protein kinases distinct from protein kinase C and protein kinase A. Mol Cell Biol 15: 6386—6397.[Abstract]
• Jeyaseelan R., Poizat C., Baker RK, Abdishoo S., Isterabadi LB, Lyons GE, Kedes L. (1997). A novel cardiac-restricted target for doxorubicin. J Biol Chem 272: 22800—22808.[Abstract/Free Full Text]
• Wang L., Ma W., Markovich R., Lee WL, Wang PH ( 1998). Insulin-like growth-factor I modulates induction of apoptotic signaling in H9c2 cardiac muscle cells. Endocrinology 139: 1354—1360.[Abstract/Free Full Text]
• Kumar D., Kirshenbaum L., Li T., Danelisen I., Singal P. (1999). Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann NY Acad Sci 874: 156—168.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Morjani H., Pignon B., Millot JM, Debal V., Lamiable D., Potron G., Etienne JC, Manfait M. (1992). Intranuclear concentration measurements of doxorubicin in living leukocytes from patients treated for a lympho-proliferative disorder. Leuk Res 16: 647—653.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Long DJN, Jaiswal AK (2000). Mouse NRH: quinone oxidoreductase (NQO2): Cloning of cDNA and gene- and tissue specific expression. Gene 252: 107—117.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wang YM, Madanat FF, Kimball JC, Gleiser CA, Ali MK, Kaufman MW, van Eys J. (1980). Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Res 40: 1022—1027.[Abstract/Free Full Text]
• Prestera T., Holtzclaw WD, Zhang Y., Talalay P. (1993). Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 90: 2965—2969.[Abstract/Free Full Text]
• Inamdar NM, Ahn YI, Alam J. ( 1996). The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences MAF and NF-E2 transcription factors. Biochem Biophys Res Commun 221: 570—576.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Prestera T., Talalay P., Alam J., Ahn YI, Lee PJ, Choi AM (1995). Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: Regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1: 827—837.[Web of Science][Medline] [Order article via Infotrieve]
• Elbirt KK, Bonkovsky HL (1999). Heme oxygenase: Recent advances in understanding its regulation and role. Proc Assoc Am Phys 111: 438—447.[Web of Science][Medline] [Order article via Infotrieve]
• Vile GF, Basu-Modak S., Waltner C., Tyrrell RM (1994). Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci USA 91: 2607—2610.[Abstract/Free Full Text]
• Tsuji Y., Ayaki H., Whitman SP, Morrow CS, Torti SV, Torti FM (2000). Coordinate transcriptional and translational regulation offerritin in response to oxidative stress. Mol Cell Biol 20: 5818—5827.[Abstract/Free Full Text]
• Dorner A., Schultheiss HP (2000). The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy. Herz 25: 176—180.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Van Vleet JF, Ferrans VJ, Badylak SF (1982). Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs. Am J Vet Res 43: 2173—2182.[Web of Science][Medline] [Order article via Infotrieve]
• Kahl S., Elsasser TH, Blum JW ( 2000). Effect of endotoxin challenge on hepatic 5'-deiodinase activity in cattle. Domest Anim Endocrinol 18: 133— 143.
• Ito H., Miller SC, Billingham ME, Akimoto H., Torti SV, Wade R., Gahlmann R., Lyons G., Kedes L., Torti FM (1990). Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci USA 87: 4275—4279.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 30, No. 4, 452-469 (2002)
DOI: 10.1080/01926230290105604


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. T. Morgan, M. Pino, L. M. Crosby, Min Wang, T. C. Elston, Z. Jayyosi, M. Bonnefoi, and G. Boorman Complementary Roles for Toxicologic Pathology and Mathematics in Toxicogenomics, With Special Reference to Data Interpretation and Oscillatory Dynamics Toxicol Pathol, January 1, 2004; 32(1_suppl): 13 - 25. [Abstract] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roger Brown, H. Articles by Morgan, K. T. Search for Related Content PubMed PubMed Citation Articles by Roger Brown, H. Articles by Morgan, K. T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood and Blood Disorders Cardiomyopathy Hazardous Substances DB DOXORUBICIN Social Bookmarking                         What's this?